Bid opening is coming soon!

On November 22, the Guangdong Pharmaceutical Trade Center issued the "Notice on Carrying out Online Quotation Work for 45 Pharmaceutical Groups Including Amoxicillin in the Guangdong Alliance".

The "Notice" stated that the enterprises that collected qualified and declared products in this alliance can go to the site to watch the information disclosure process

The following is a brief list:

Review of the progress of this volume purchase

On November 4, the Guangdong Pharmaceutical Trade Center issued the official version of the "Guangdong Union Amoxicillin and Other 45 Pharmaceutical Groups Procurement Documents", announcing the official start of this large-scale inter-provincial alliance mass procurement

The initial reporting documents of the Pharmaceutical Purchasing Alliance led by Guangdong Province show that Shanxi, Fujian, Jiangxi, Henan, Hubei, Hunan, Guangxi, Hainan, Guizhou, Yunnan, Shaanxi, Gansu, Qinghai, Ningxia, Xinjiang and other provinces (autonomous regions) have medical insurance The Bureau and the Medical Security Bureau of the Xinjiang Production and Construction Corps issued an invitation, covering a total of 16 provinces and regions, covering half of China

On July 17 this year, the Guangdong Pharmaceutical Trade Center issued the "Draft for Solicitation of Comments" (see MRCLUB historical news: 45 drugs! The Guangdong Inter-Provincial Alliance has confirmed the scope of the bulk purchase variety).

According to the "Procurement Documents", the scope of the drug group's bulk purchases is the first and third batches of the country's first and third batches of all the dosage forms and specifications of 45 drugs of the same variety, including amoxicillin, which expires at the end of 2021.

As of the date of the issuance of this procurement document, the number of generic drugs that have passed (including deemed passing, the same below) consistency evaluation exceeds one (including this number) and the formulations of the national medical insurance drug catalog are not included in this collection.

Flurbiprofen sustained-release and controlled-release dosage form is an exclusive variety and has been discontinued.

In principle, the volume procurement cycle for the drug alliance area of ​​this product range does not exceed two years, and it will be calculated from the actual implementation date of the selected results

In addition, it should be noted that when the purchase period of the first year ends and the purchase agreement is renewed in the second year, if the actual purchase volume of the selected company exceeds the total amount of pre-purchasing in the first year of the purchase period and the second-tier quotation is not executed, the renewal price will be taken The company's second-tier quotation